It seems paradoxical that HPN plays a role in HCC based on its down-regulation in our and other reports [41, 42], as its level was up-regulated in other cancers such as ovarian carcinoma, renal cell carcinoma, and prostate cancer as reported in previous studies [43–45]. This evidence concerns the gene HPN and prostate carcinoma.